JENNIFER FOSTER to Disease-Free Survival
This is a "connection" page, showing publications JENNIFER FOSTER has written about Disease-Free Survival.
Connection Strength
0.233
-
The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma. Expert Opin Drug Saf. 2018 Dec; 17(12):1257-1262.
Score: 0.122
-
Minimal residual disease detected prior to hematopoietic cell transplantation. Pediatr Blood Cancer. 2011 Jul 15; 57(1):163-5.
Score: 0.071
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
Score: 0.039